ici 118551 and esmolol

ici 118551 has been researched along with esmolol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Selvam, B; Tikhonova, IG; Wereszczynski, J1
Funao, T; Kawai, S; Matsuura, T; Nishikawa, K; Yamada, T1

Other Studies

2 other study(ies) available for ici 118551 and esmolol

ArticleYear
Comparison of dynamics of extracellular accesses to the β(1) and β(2) adrenoceptors binding sites uncovers the potential of kinetic basis of antagonist selectivity.
    Chemical biology & drug design, 2012, Volume: 80, Issue:2

    Topics: Adrenergic beta-Antagonists; Binding Sites; Drug Design; Humans; Molecular Dynamics Simulation; Propanolamines; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2

2012
Neuropathic pain attenuates ischemia reperfusion injury through β2-adrenergic pathway.
    Life sciences, 2017, Oct-15, Volume: 187

    Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-2 Receptor Antagonists; Animals; Hemodynamics; Hyperalgesia; Isolated Heart Preparation; Ligation; Male; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Myocardial Infarction; Myocytes, Cardiac; Neuralgia; Phosphotransferases; Propanolamines; Protective Factors; Rats; Reperfusion Injury; Spinal Cord

2017